Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Hepatocellular carcinoma" and "Society guideline links: Hepatitis C infection in solid organ transplant candidates and recipients".)
International
●Kidney Disease: Improving Global Outcomes (KDIGO): Clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease (2022)
●World Health Organization (WHO): Consolidated guidelines on HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and care for key populations (2022)
●WHO: Updated recommendations on treatment of adolescents and children with chronic HCV infection and HCV simplified service delivery and diagnostics (2022)
●WHO: Recommendations and guidance on hepatitis C virus self-testing (2021)
●WHO: Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection (2018)
●World Gastroenterology Organisation (WGO): Global guidelines on diagnosis, management, and prevention of hepatitis C, update (2017)
●WHO: Guidelines on hepatitis B and C testing (2017)
Canada
●Public Health Agency of Canada (PHAC): Hepatitis C – For health professionals (2023)
●Choosing Wisely Canada: Don't repeat hepatitis C viral load testing in an individual who has established chronic infection, outside of antiviral treatment (2022)
●Canadian Paediatric Society (CPS): Position statement for the management of infants, children, and youth at risk for hepatitis C virus (HCV) infection (2021)
●North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN): Position paper on hepatitis C in 2020 (2020)
●Canadian Association for the Study of the Liver (CASL): Guideline for the management of chronic hepatitis C, update (2018)
●Canadian Task Force on Preventive Health Care (CTFPHC): Recommendations on hepatitis C screening for adults (2017)
United States
●Centers for Disease Control and Prevention (CDC): Hepatitis C resources for health care professionals
•Clinical screening and diagnosis for hepatitis C
●American Academy of Pediatrics (AAP): Red Book – Hepatitis C (2024)
●US Department of Health and Human Services (HHS): Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV – Hepatitis C virus infection (2023, reviewed 2024)
●American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA): HCV guidelines
•AASLD-IDSA: Hepatitis C guidance – Recommendations for testing, managing, and treating hepatitis C virus infection, update (2023)
●North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN): Position paper on hepatitis C in 2020 (2020)
●Society for Healthcare Epidemiology of America (SHEA): White paper for the management of healthcare personnel living with hepatitis B, hepatitis C, or human immunodeficiency virus in US healthcare institutions (2020)
●US Preventive Services Task Force (USPSTF): Final recommendation statement on hepatitis C virus infection in adolescents and adults – Screening (2020)
●American Gastroenterological Association (AGA): Clinical practice expert review for the care of patients who have achieved a sustained virologic response after antiviral therapy for chronic hepatitis C infection, update (2017)
●AGA: Hepatitis C virus infection care pathway (2017)
Europe
●European Association for the Study of the Liver (EASL): Recommendations on treatment of hepatitis C, update (2020)
●European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN): A position paper for treatment of chronic hepatitis C virus infection in children (2018)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Public health guideline on hepatitis B and C testing – People at risk of infection (2012, updated 2013)
●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline for management of hepatitis C (2013)
India
●Asian Pacific Association for the Study of the Liver (APASL): Consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing (2016)
●APASL: Consensus statements and recommendation on treatment of hepatitis C (2016)
Australia–New Zealand
●Australasian Sexual and Reproductive Health Alliance (ASRHA) and Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM): Australian STI management guidelines for use in primary care – Hepatitis C
●Gastroenterological Society of Australia (GESA), Australasian Society for Infectious Diseases (ASID), ASHM, Australasian Hepatology Association (AHA), Hepatitis Australia, and Royal Australian College of General Practitioners (RACGP): Australian recommendations for the management of hepatitis C virus infection – A consensus statement (2022)
●GESA, ASID, Hepatitis Australia and Primary Care: HCV in children – Australian commentary on American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (AASLD-IDSA) guidance (2021)
●Asian Pacific Association for the Study of the Liver (APASL): Consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing (2016)
●APASL: Consensus statements and recommendation on treatment of hepatitis C (2016)
Japan
●[In Japanese] Japan Society of Hepatology (JSH): Hepatitis C treatment guidelines (2023)
●[In English] Japanese Society of Pediatric Nutrition, Gastroenterology, and Hepatology (JSPGHAN), Japanese Society of Pediatric Infectious Diseases (JSPID), JSH, and Japan Society of Obstetrics and Gynecology (JSOG): Clinical practice guidelines for the management of children with mother-to-child transmitted hepatitis C virus infection (2022)
●[In Japanese] JSPGHAN, JSPID, JSH, and JSOG: Clinical practice guidelines for the management of children with mother-to-child transmitted hepatitis C virus infection (2020)
●[In English] Asian Pacific Association for the Study of the Liver (APASL): Consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing (2016)
●[In English] APASL: Consensus statements and recommendation on treatment of hepatitis C (2016)
